Natixis Bausch Health Companies Inc. Transaction History

Natixis

  • $17.6 Billion
  • Q3 2024

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$7.77 - $10.61 $3.54 Million - $4.84 Million
456,000 Added 14.27%
3,652,200 $38.7 Million
Q4 2023

Feb 13, 2024
SELL
$6.53 - $8.23 $2.87 Million - $3.61 Million
-439,000 Reduced 12.08%
3,196,200 $25.6 Million
Q3 2023

Nov 14, 2023
BUY
$7.69 - $9.71 $1.81 Million - $2.28 Million
235,200 Added 6.92%
3,635,200 $29.9 Million
Q2 2023

Aug 11, 2023
SELL
$5.72 - $8.8 $26.3 Million - $40.5 Million
-4,600,000 Reduced 57.5%
3,400,000 $27.2 Million
Q1 2023

May 12, 2023
SELL
$6.28 - $9.85 $49.1 Million - $77 Million
-7,817,975 Reduced 49.42%
8,000,000 $64.8 Million
Q4 2022

Feb 24, 2023
BUY
$6.09 - $7.93 $47.6 Million - $62 Million
7,817,975 Added 97.72%
15,817,975 $99.3 Million
Q3 2022

Nov 14, 2022
BUY
$4.58 - $9.21 $34.2 Million - $68.8 Million
7,469,000 Added 1406.59%
8,000,000 $55.1 Million
Q2 2022

Aug 12, 2022
SELL
$7.06 - $23.63 $408,964 - $1.37 Million
-57,927 Reduced 9.84%
531,000 $4.44 Million
Q1 2022

May 13, 2022
BUY
$21.6 - $27.79 $12.7 Million - $16.4 Million
588,927 New
588,927 $13.5 Million
Q1 2021

May 14, 2021
SELL
$21.37 - $34.38 $15.3 Million - $24.6 Million
-716,606 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$15.31 - $21.12 $11 Million - $15.1 Million
716,606 New
716,606 $14.9 Million

Others Institutions Holding BHC

# of Institutions
254
Shares Held
253M
Call Options Held
5.53M
Put Options Held
16.5M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email